Skip to content

XOMA Corporation XOMA Reclassification Of Equity Classified Awards To Liabilities

Reclassification Of Equity Classified Awards To Liabilities at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
-$639.5K
PureCycle Technologies, Inc. logo
PureCycle Technologies, Inc.PCT
$81K
Cipher Digital, Inc.
 logo
Cipher Digital, Inc. CIFR
$184.25M
Churchill Downs logo
Churchill DownsCHDN
$5.23M
Jade Biosciences, Inc. Common Stock logo
Jade Biosciences, Inc. Common StockJBIO
$2.79M
Bright Horizons Family Solutions logo
Bright Horizons Family SolutionsBFAM
$0-100%

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$745.16M+159%
Enterprise value$784.29M+151%
P/E22×
P/S15.4×+8.6×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Reported directly by XOMA Corporation in its filing.

Tagged under the XBRL concept xoma:ReclassificationOfEquityClassifiedAwardsToLiabilities.

The official record: XOMA Corporation’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's reclassification of equity classified awards to liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's reclassification of equity classified awards to liabilities?
XOMA Corporation (XOMA) reported reclassification of equity classified awards to liabilities of -$184.75K in Q4 2025.
What does reclassification of equity classified awards to liabilities mean?
Represents the non-cash adjustment resulting from changing the classification of stock-based compensation awards from equity to liabilities. This shift often occurs due to changes in award terms or settlement expectations, impacting the balance sheet structure.